Cannabinoids in supportive care: are they necessary?
Bruera
Eduardo
E
Castro
Monica
M
D000970:Antineoplastic Agents / Q000009:adverse effects*; D019167:Appetite Stimulants / Q000627:therapeutic use; D002100:Cachexia / Q000188:drug therapy; D063385:Cannabinoid Receptor Modulators; D002186:Cannabinoids / Q000009:adverse effects / Q000627:therapeutic use*; D002493:Central Nervous System Diseases / Q000139:chemically induced; D026690:Ethics, Clinical; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology; D006801:Humans; D009325:Nausea / Q000139:chemically induced* / Q000188:drug therapy*; D009369:Neoplasms / Q000188:drug therapy*; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug / Q000187:drug effects; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D019167:Appetite Stimulants; D063385:Cannabinoid Receptor Modulators; D002186:Cannabinoids; D005231:Fatty Acids, Unsaturated; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug